Medicine
Dextrose and Lidocaine 12.5 g/2 g per 250 mL injection
Dextrose and Lidocaine 12.5 g/2 g per 250 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage in automated dispensing machines: Brief exposure up to 2 weeks to…
Key facts
- Active ingredient (INN)
- Dextrose and Lidocaine
- Brand
- Sold under the generic name
- Strength
- 12.5 g/2 g per 250 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 24 containers of 250 mL
- Manufacturer
- B. Braun Medical
- Origin register
- US FDA, United States
- Storage
- Storage in automated dispensing machines: Brief exposure up to 2 weeks to ultraviolet or fluorescent light does not adversely affect the product labeling legibility, prolonged exposure can cause fading of the red label.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 April 1992
- Identifiers
- RxCUI 1737723, 1737742, 1737744DailyMed set ID 7dff29d9-522d-40eb-a9d9-42377912d640NDC 0264-9598Application NDA019830
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 container in 1 case / 250 mL in 1 container | 0264-9598-20 | B. Braun Medical | 8 April 1992 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dextrose and Lidocaine
Clinical summary
Dextrose and Lidocaine is a fixed-dose combination of an amide local anesthetic and an antiarrhythmic indicated in the acute management of ventricular arrhythmias occurring during cardiac manipulations, among other approved uses. MedsAcross supplies Dextrose and Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Dextrose and LidocaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lidocaine Hydrochloride and Dextrose prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Dextrose and Lidocaine 12.5 g/2 g per 250 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.